Profile

Edward A. Levine, M.D.Wake Forest Baptist Health

Doctor Rating

4.6 out of 5

252 Ratings
26 Comments

Edward A. Levine, M.D.

Chief,
Director-At-Large,
Core Director,
Professor,


Clinical Interests

Sarcoma, Gastrointestinal Tumors, Esophageal Cancer, Mesothelioma, Peritoneal Carcinomatosis, Esophageal Tumors, Melanoma, Breast Cancer

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-4276
Department: 336-716-0545

Email: elevine@wakehealth.edu

Insurance Accepted »

Media Medical Expert »

Education & Training

  • B.S., Northern Illinois University, 1981
  • M.D., Finch University of Health Sci/Chicago Med School, 1985
  • Residency, Surgery, Michael Reese Hosp/Med Ctr, 1990
  • Residency, Oncology, U Illinois Hospital, 1992

Memberships

  • Nat'L Surgical Adjuvant For Br
  • North Carolina Medical Society
  • Soc Of Surg Of Alimentary Trac
  • Southern Assn For Oncology
  • Southern Medical Association
  • Southern Surgical Assn
  • Southern Surgical Congress
  • Winston-Salem Surgical Society
  • Am Hepato-Pancreato-Biliary
  • Am Coll Of Surgeons
  • Assn Of Academic Surgery
  • Connective Tissue Oncology Soc
  • Alpha Omega Alpha

NPI Number

  • 1275518334
Edward A. Levine, M.D.

Doctor Rating

4.6 out of 5

252 Ratings
26 Comments

Edward A. Levine, M.D.

Chief, Surgical Oncology
Director-At-Large, Comprehensive Cancer Center
Core Director, Comprehensive Cancer Center
Professor, Surgical Oncology
Comprehensive Cancer Center
Office of Women in Medicine and Science

Research Interests

cancer/oncogenesis

Contact Information

Academic: 336-716-0545 | Department: 336-716-0545

Email: elevine@wakehealth.edu

Media Medical Expert »

Recent Publications

Doud AN, Randle RW, Clark CJ, Levine EA, Swett KR, Shen P, Stewart JH, Votanopoulos KI. Impact of distal pancreatectomy on outcomes of peritoneal surface disease treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2015;22(5):1645-1650.

Randle RW, Doud AN, Levine EA, Clark CJ, Swett KR, Shen P, Stewart JH, Votanopoulos KI. Peritoneal surface disease with synchronous hepatic involvement treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2015;22(5):1634-1638.

Votanopoulos KI, Russell G, Randle RW, Shen P, Stewart JH, Levine EA. Peritoneal surface disease (PSD) from appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): overview of 481 cases. Ann Surg Oncol. 2015;22(4):1274-1279.

Jin LX, Moses LE, Squires MH III, Poultsides GA, Votanopoulos K, Weber SM, Bloomston M, Pawlik TM, Hawkins WG, Linehan DC, Strasberg SM, Schmidt C, Worhunsky DJ, Acher AW, Cardona K, Cho CS, Kooby DA, Levine E, Winslow ER, Saunders ND,. Factors associated with recurrence and survival in lymph node-negative gastric adenocarcinoma: a 7-institution study of the US Gastric Cancer Collaborative. Ann Surg. 2015;():.

Randle RW, Ahmed S, Levine EA, Fino NF, Swett KR, Stewart JH, Shen P, Votanopoulos KI. Significance of diabetes on morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2015;111(6):740-745.

Spolverato G, Ejaz A, Kim Y, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Votanopoulos K, Acher AW, Jin LX, Hawkins WG, Schmidt C, Kooby DA, Worhunsky D, Saunders N, Cho CS, Levine EA, Maithel SK, Pawlik TM. Prognostic performance of different lymph node staging systems after curative intent resection for gastric adenocarcinoma. Ann Surg. 2015;():.

Acher AW, Squires MH, Fields RC, Poultsides GA, Schmidt C, Votanopoulos KI, Pawlik TM, Jin LX, Ejaz A, Kooby DA, Bloomston M, Worhunsky D, Levine EA, Saunders N, Winslow E, Cho CS, Meredith K, Leverson G, Maithel SK, Weber SM. Can the risk of non-home discharge after resection of gastric adenocarcinoma be predicted: a seven-institution study of the US Gastric Cancer Collaborative. J Gastrointest Surg. 2015;19(2):207-216.

Kim Y, Ejaz A, Spolverato G, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Votanopoulos K, Acher AW, Jin LX, Hawkins WG, Schmidt C, Kooby D, Worhunsky D, Saunders N, Cho CS, Levine EA, Maithel SK, Pawlik TM. Conditional survival after surgical resection of gastric cancer: a multi-institutional analysis of the US Gastric Cancer Collaborative. Ann Surg Oncol. 2015;22(2):557-564.

Faig J, Howard S, Levine EA, Casselman G, Hesdorffer M, Ohar JA. Changing pattern in malignant mesothelioma survival. Transl Oncol. 2015;8(1):35-39.

Randle RW, Griffith KF, Fino NF, Swett KR, Stewart JH IV, Shen P, Levine EA, Votanopoulos KI. Appendiceal goblet cell carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Res. 2015;196(2):229-234.

Squires MH III, Kooby DA, Poultsides GA, Pawlik TM, Weber SM, Schmidt CR, Votanopoulos KI, Fields RC, Ejaz A, Acher AW, Worhunsky DJ, Saunders N, Levine EA, Jin LX, Cho CS, Bloomston M, Winslow ER, Russell MC, Cardona K, Staley CA, Maithel SK. Is it time to abandon the 5-cm margin rule during resection of distal gastric adenocarcinoma? A multi-institution study of the U.S. Gastric Cancer Collaborative. Ann Surg Oncol. 2015;22(4):1243-1251.

Schwarz L, Votanopoulos K, Morris D, Yonemura Y, Deraco M, Piso P, Moran B, Levine EA, Tuech JJ. Is the combination of distal pancreatectomy and cytoreductive surgery with HIPEC reasonable? Results of an International Multicenter study. Ann Surg. 2015;():.

Doud AN, Levine EA, Fino NF, Stewart JH, Shen P, Votanopoulos KI. Stoma creation and reversal after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2015;():.

Kim Y, Spolverato G, Ejaz A, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Votanopoulos K, Acher AW, Jin LX, Hawkins WG, Schmidt C, Kooby D, Worhunsky D, Saunders N, Levine EA, Cho CS, Maithel SK, Pawlik TM. A nomogram to predict overall survival and disease-free survival after curative resection of gastric adenocarcinoma. Ann Surg Oncol. 2015;22(6):1828-1835.

Levine EA, Stewart JH IV, Shen P, Russell GB, Loggie BL, Votanopoulos KI. Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. J Am Coll Surg. 2014;218(4):573-585.

Votanopoulos KI, Randle RW, Craven B, Swett KR, Levine EA, Shen P, Stewart JH, Mirzazadeh M. Significance of urinary tract involvement in patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2014;21(3):868-874.

Randle RW, Swett KR, Swords DS, Shen P, Stewart JH, Levine EA, Votanopoulos KI. Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascites. Ann Surg Oncol. 2014;21(5):1474-1479.

Blackham AU, Swett K, Eng C, Sirintrapun J, Bergman S, Geisinger KR, Votanopoulos K, Stewart JH, Shen P, Levine EA. Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2014;109(7):740-745.

Ahmed S, Levine EA, Swett KR, Randle RW, Shen PW, Stewart JH, Votanopoulos KI. Significance of diaphragmatic resections and thoracic chemoperfusion on outcomes of peritoneal surface disease treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) [abstract]. Ann Surg Oncol. 2014;21(Suppl 1):S135.

Bryan M, D'Agostino R, Brown D, Levine E, Howard-McNatt M. Is postmastectomy radiation therapy indicated in patients with close or positive margins? [abstract]. Ann Surg Oncol. 2014;21(Suppl 2):33.

Votanopoulos KI, Russell G, Randle RW, Shen PW, Stewart JH, Levine EA. Peritoneal surface disease (PSD) from appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): overview of 481 cases [abstract]. Ann Surg Oncol. 2014;21(Suppl 1):S128-S129.

Randle RW, Swett KR, Stewart JH, Shen P, Levine EA, Votanopoulos KI. Morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with diabetes [abstract]. Ann Surg Oncol. 2014;21(Suppl 1):S87.

Jin LX, Squires MH, Poultsides G, Votanopoulos KI, Weber SM, Bloomston M, Pawlik T, Hawkins WG, Linehan D, Strasberg SM, Archer AW, Cardona K, Cho C, Kooby DA, Levine EA, Winslow E, Saunders ND, Spolverato G, Maithel SK, Fields RC. Factors associated with recurrence in lymph node-negative gastric adenocarcinoma: results from the US Gastric Cancer Collaborative [abstract]. Ann Surg Oncol. 2014;21(Suppl 1):S173.

Salazar R, Capdevila J. Rosenberg R, de Waard JW, Glimelius B, Bibeau F, Klaase J, Van der Hoeven JJM, Midgley RA, Chang GJ, Bachleitner-Hofmann T, Asano M, Ziebermayr R, Levine EA, Deck KB, Sington J, Law WL, Shbeeb I, Stork L, Marshall J. Comparison of ColoPrint risk classification with clinical risk in the prospective PARSC trial [abstract]. J Clin Oncol. 2014;32(3 Suppl):465.

Turaga K, Levine E, Barone R, Sticca R, Petrelli N, Lambert L, Nash G, Morse M, Adbel-Misih R, Alexander HR, Attiyeh F, Bartlett D, Bastidas A, Blazer T, Chu Q, Chung K, Dominguez-Parra L, Espat NJ, Foster J, Fournier K, Garcia R, Goodman M,. Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States. Ann Surg Oncol. 2014;21(5):1501-1505.

Sirintrapun SJ, Blackham AU, Russell G, Votanopoulos K, Stewart JH, Shen P, Levine EA, Geisinger KR, Bergman S. Significance of signet ring cells in high-grade mucinous adenocarcinoma of the peritoneum from appendiceal origin. Hum Pathol. 2014;45(8):1597-1604.

Blackham AU, Russell GB, Stewart JH IV, Votanopoulos K, Levine EA, Shen P. Metastatic colorectal cancer: survival comparison of hepatic resection versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2014;21(8):2667-2674.

Shen P, Thomas CR, Fenstermaker J, Aklilu M, McCoy TP, Levine EA. Phase II trial of adjuvant oral thalidomide following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface disease from colorectal/appendiceal cancer. J Gastrointest Cancer. 2014;45(3):268-275.

Ahmed S, Levine EA, Randle RW, Swett KR, Shen P, Stewart JH, Votanopoulos KI. Significance of diaphragmatic resections and thoracic chemoperfusion on outcomes of peritoneal surface disease treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2014;21(13):4226-4231.

Randle RW, Levine EA, Clark CJ, Stewart JH, Shen P, Votanopoulos KI. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for gallbladder cancer: a retrospective review. Am Surg. 2014;80(7):710-713.

Ahmed S, Lawrence J, Stewart JH, Melin S, Levine EA, Howard-McNatt M. Does age predict outcome in patients with inflammatory breast cancer?. Am Surg. 2014;80(8):E221-E224.

Starr B, Davis S, Ayala-Peacock D, Blackstock WA, Levine EA. Reassessment of the role of enteral tube feedings for patients with esophageal cancer. Am Surg. 2014;80(8):752-758.

Ahmed S, Stewart JH, Shen P, Votanopoulos KI, Levine EA. Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis. J Surg Oncol. 2014;110(5):575-584.

Bryan ML, Fitzgerald NC, Levine EA, Shen P, Stewart JH, Votanopoulos KI. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in sarcomatosis from gastrointestinal stromal tumor. Am Surg. 2014;80(9):890-895.

Lee E, Levine EA, Franco VI, Allen GO, Gong F, Zhang Y, Hu JJ. Combined genetic and nutritional risk models of triple negative breast cancer. Nutr Cancer. 2014;66(6):955-963.

Kusamura S, Moran BJ, Sugarbaker PH, Levine EA, Elias D, Baratti D, Morris DL, Sardi A, Glehen O, Deraco M. Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei. Br J Surg. 2014;101(13):1758-1765.

Squires MH III, Kooby DA, Pawlik TM, Weber SM, Poultsides G, Schmidt C, Votanopoulos K, Fields RC, Ejaz A, Acher AW, Worhunsky DJ, Saunders N, Jin LX, Levine E, Cho CS, Bloomston M, Winslow E, Cardona K, Staley CA III, Maithel SK. Utility of the proximal margin frozen section for resection of gastric adenocarcinoma: a 7-institution study of the US Gastric Cancer Collaborative. Ann Surg Oncol. 2014;21(13):4202-4210.

Votanopoulos K, Ihemelandu C, Shen P, Stewart J, Russell G, Levine EA. A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C. J Surg Res. 2013;179(1):e133-e139.

Addington E, Russell G, Tedeschi R, Levine E, Shen P, Stewart J, Danhauer S, Duckworth K, McQuellon R. Post-traumatic growth is sustained two years after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy [abstract]. Psychooncology. 2013;22(Suppl 2):54.

Sirintrapun J, Blackham A, Russell G, Stewart J, Shen P, Levine E, Geisinger K, Bergman S, Cimic A. Significance of signet-ring cells in extracellular mucin pools versus tissue in high-grade mucinous carcinoma peritonei [abstract]. Lab Invest. 2013;93(Suppl 1):180A.

Votanopoulos KI, Swett K, Blackham AU, Ihemelandu C, Shen P, Stewart JH, Levine EA. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from rectal cancer. Ann Surg Oncol. 2013;20(4):1088-1092.

Ihemelandu C, Levine EA, Aklilu M, Yacoub G, Howerton R, Bolemon B, Graham M, Russell G, Shen P. Optimal timing of systemic therapy in resectable colorectal liver metastases. Am Surg. 2013;79(4):414-421.

Stolier AJ, Levine EA. Reducing the risk of nipple necrosis: technical observations in 340 nipple-sparing mastectomies. Breast J. 2013;19(2):173-179.

Duckworth K, McQuellon R, Russell G, Campbell C, Shen P, Stewart J IV, Levine E. Patient preparedness and treatment satisfaction following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS+HIPEC) [abstract]. Psychooncology. 2013;22(Suppl 2):54-55.

Howard-McNatt M, Lawrence J, Melin SA, Levine EA, Shen P, Stewart JH IV. Race and recurrence in women who undergo neoadjuvant chemotherapy for breast cancer. Am J Surg. 2013;205(4):397-401.

O'Flaherty JT, Wooten RE, Samuel MP, Thomas MJ, Levine EA, Case LD, Akman SA, Edwards IJ. Fatty acid metabolites in rapidly proliferating breast cancer. PLoS One. 2013;8(5):e63076.

Blackham A, Swett K, Eng C, Sirintrapun J, Bergman S, Geisinger K, Votanopoulos KI, Stewart JH, Shen P, Levine E. Perioperative systemic chemotherapy for metastatic appendiceal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [abstract]. Ann Surg Oncol. 2013;20(Suppl 1):S13.

Kusamura S, Deraco M, Baratti D, Moran B, Sugarbaker PH, Levine E, Dominique E, Morris D, Chua T, Sardi A, Glehen O, Gilly F, Barrios P, Portilla AG, de Hingh IHJT, Ceelan WP, Pelz JW, Pompiliu P, Gonzalez-Moreno S,. Learning curve and surgical performance of cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei: a PSOGI multicentric study [abstract]. Ann Surg Oncol. 2013;20(Suppl 1):S13.

Newman NA, Lucas JT, Peacock DA, Trottman PA, Wentworth SS, Winters SM, Levine E, Shen P. Predictors for readmission after pancreatic resection for malignancy [abstract]. Ann Surg Oncol. 2013;20(Suppl 1):S140.

Randle RW, Swett KR, Shen P, Stewart JH, Levine EA, Votanopoulos KI. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal sarcomatosis. Am Surg. 2013;79(6):620-624.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Surgical Oncology

Clinical Interests

Sarcoma, Gastrointestinal Tumors, Esophageal Cancer, Mesothelioma, Peritoneal Carcinomatosis, Esophageal Tumors, Melanoma, Breast Cancer
Edward A. Levine, M.D.

Edward A. Levine, M.D.

Chief, Surgical Oncology
Director-At-Large, Comprehensive Cancer Center
Core Director, Comprehensive Cancer Center
Professor, Surgical Oncology
Comprehensive Cancer Center
Office of Women in Medicine and Science

Doctor Rating

4.6 out of 5

Edward A. Levine, M.D.252 Ratings
26 Comments

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.7
CP efforts to include in decisions
4.7
CP explanations of prob/condition
4.7
CP spoke using clear language
4.7
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.7
Patients' confidence in CP
4.8
Time CP spent with patient
4.6
Wait time at clinic
3.4



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

6/24/2015

dr Levine is a very caring person. the hospital is very fortunate to have him

6/12/2015

I would recommend this care provider for any surgical oncology

6/8/2015

Great Dr. just follow-up too long in room!

6/3/2015

Dr. Levine is the backbone that supports the principles of a research and teaching hospital.

5/18/2015

Dr. Levine is a true professional.

5/11/2015

*Dr. Levine & his staff are extra good!!

4/22/2015

All the confidence in the world in *Dr Levine!

3/23/2015

I would recommend everyone to others

3/22/2015

I would not have the medical expertise to recommend Dr. Levine to another person but if a patient were recommended to Dr. Levine I would certainly recommend Dr. Levine favorably.

2/26/2015

The wait time to see the care provider is disrespectful and uncaring regarding my time!!!

2/4/2015

I have already recommended my provider to several people.

1/30/2015

I feel *Dr. Levine would have spent as much time as need with me -

1/26/2015

Dr. Levine is the best

1/21/2015

Best doctor that I know!

1/5/2015

Best surgeon ever been to... excellent "bedside" manner & technical skills -

12/31/2014

Dr. Levine and his team answered all questions and made us feel confident in going forward

12/31/2014

Dr Levine is top notch!

10/30/2014

One of the most professional and caring experiences of my life

10/28/2014

Dr. Levine and his staff were all of these, and more.

10/24/2014

I have recommended *Dr. Levine & hospital on numerous occasions.

10/22/2014

Great experience.

9/23/2014

excellent patient experience

9/22/2014

So impressed with Dr. Levine and all of his staff!

9/3/2014

Loved Dr Levine....

8/27/2014

Dr. Levine saved my life...what more needs to be said?

8/11/2014

DR. LEVINE is exceptional in all regards; simply the best.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.